Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Q: What does CUSIP 501976104 represent in this 13F holders report?

CUSIP 501976104 is the security identifier for KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q3 2024?

92 institutional investors reported KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 501976104

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 28,136,737
Total 13F value: $138,294,516
Share change: -3,891,297
Put/Call ratio: 986%
SEC-reported price per share: $4.89
Number of holders: 92
Value change: -$28,965,516
Number of buys: 48
Number of sells: 43
Shares outstanding: 61,864,407

Security key

501976104

Report period

Q3 2024

Institutions

Top holders

KYTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Kyverna Therapeutics, Inc. SEC filings Kyverna Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 501976104

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bain Capital Life Science...

Disclosed value leader

Vida Ventures Advisors, LLC

Comparable rows

0/15

Latest evidence

30 Jun 2024

13F 3/4/5 Highest disclosed value: $33,929,430 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Vida Ventures Advisors, LLC has the largest disclosed position value at $33.93M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vida Ventures Advisors, LLC's linked filing trail.

Disclosed position value Top 5

Bain Capital Life Sciences Invest... $25.26M

Vida Ventures Advisors, LLC $33.93M

Northpond Ventures, LLC $24.42M

JPMORGAN CHASE & CO $15.46M

DEERFIELD MANAGEMENT COMPANY, L.P. $14.87M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bain Capital Life Sciences Investors, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$25,262,775 3,368,370 shares	—	30 Jun 2024
Vida Ventures, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 4,777,060 shares	—	12 Feb 2024
GILEAD SCIENCES, INC.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 4,126,119 shares	—	12 Feb 2024
Northpond Ventures III GP, LLC	3/4/5 Former 10% Owner 3/4/5	— denominator unverified	— 3,255,426 shares	—	12 Feb 2024
Westlake BioPartners Fund I, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 735,984 shares	—	12 Feb 2024
Vida Ventures Advisors, LLC	13F Company 13F	— denominator unverified	$33,929,430 4,523,924 shares	—	30 Jun 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

28,136,737

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend